Literature DB >> 10850615

Microdialysis sampling coupled to HPLC for transdermal delivery study of ondansetron hydrochloride in rats.

P Ding1, H Xu, G Wei, J Zheng.   

Abstract

The transdermal delivery of ondansetron hydrochloride (ON) solution in propylene glycol (PG) with a widely used penetration enhancer, oleic acid (OA), was studied in rats by a microdialysis sampling technique. Dialysate samples collected from the probe were directly injected into the HPLC system without any pre-treatment and no interference occurred in the blank sample. A good linearity between the standard concentrations and peak areas within the calibration range was achieved. In vivo recovery (32.52 +/- 1.8%) of the probe was assessed with the retrodialysis method, which was used to calculate the ON concentration in the dermis. Oleic acid at the concentrations of 2% and 5% (w/v) increased the steady-state delivery rate from 0.001 to 0.030 and 0.058 microg/h, respectively. OA proved to be an effective enhancer for transdermal delivery of ON in rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10850615     DOI: 10.1002/1099-0801(200005)14:3<141::AID-BMC937>3.0.CO;2-Z

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  3 in total

Review 1.  Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future.

Authors:  Christian Joukhadar; Markus Müller
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  In vivo methods for the assessment of topical drug bioavailability.

Authors:  Christophe Herkenne; Ingo Alberti; Aarti Naik; Yogeshvar N Kalia; François-Xavier Mathy; Véronique Préat; Richard H Guy
Journal:  Pharm Res       Date:  2007-11-06       Impact factor: 4.200

3.  Tissue distribution and dermal drug determination of indomethacin transdermal-absorption patches.

Authors:  Jingjing Ma; Ying Gao; Yinghua Sun; Dawei Ding; Qi Zhang; Bingjun Sun; Menglin Wang; Jin Sun; Zhonggui He
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.